(AGENPARL) - Roma, 6 Febbraio 2025 - (AGENPARL) – gio 06 febbraio 2025 8.00 AM CET / 6-Feb-2025 / Detection Technology Oyj (FNFI:DETEC)
Detection Technology Plc company announcement 6 February 2025 at 09:00 (EET)
DETECTION TECHNOLOGY PLC FINANCIAL STATEMENTS REVIEW JANUARY-DECEMBER 2024
Detection Technology Q4 2024: A strong finish to a good year
October-December 2024 highlights
· Net sales increased by 0.9% to EUR 31.6 million (31.3)
· Net sales of Industrial Solutions Business Unit (IBU) increased by 4.2% to
EUR 5.2 million (5.0)
· Net sales of Medical Business Unit (MBU) decreased by -4.6% to EUR 12.5
million (13.1)
· Net sales of Security Business Unit (SBU) increased by 5.3% to EUR 13.9
million (13.2)
· Operating profit (EBITA) was EUR 5.2 million (4.6)
· Operating margin (EBITA-%) was 16.3% of net sales (14.8%)
· Earnings per share were EUR 0.28 (0.24)
· Earnings per share (diluted) were EUR 0.28 (0.24)
January-December 2024 highlights
· Net sales increased by 3.6% to EUR 107.5 million (103.8)
· Net sales of IBU increased by 18.2% to EUR 19.0 (16.1)
· Net sales of MBU decreased by -12.8% to EUR 42.2 million (48.4)
· Net sales of SBU increased by 17.8% to EUR 46.3 million (39.3)
· Operating profit (EBITA) was EUR 14.9 million (8.8)
· Operating margin (EBITA-%) was 13.9% of net sales (8.5%)
· Earnings per share were EUR 0.76 (0.38)
· Earnings per share (diluted) were EUR 0.76 (0.38)
· Dividend EUR 0.50 per share* (0.23)
UNAUDITED (Figures in parentheses refer to the corresponding period of the
previous year.) (*The Board of Directors’ proposal to the AGM.)
President and CEO, Hannu Martola:
“All in all, the fourth quarter marked a strong conclusion to the year 2024,
meeting our expectations. Sales remained consistent with the record comparison
period, while profitability showed improvement, and cash flow saw a notable
increase both year-on-year and quarter-on-quarter—thanks to good productivity
and networking capital management. The Board is therefore proposing a record
dividend of EUR 0,50 per share (0,23). The past year underscores the resilience
and efficiency of our operations, even in a turbulent environment. We are well
-positioned to capitalize on new opportunities in 2025.
Our industrial solutions saw steady demand in Europe, particularly in food and
industrial CT (computed tomography) applications. In the APAC region, demand was
also strong, but intense competition put pressure on prices. As expected, our
industrial sales continued to grow quarter-on-quarter and year-on-year. However,
the growth rate was influenced by a strong comparison period and competitive
pressures from TFT (thin-film transistor) flat panel detector segment in China.
We anticipate growth to continue in Q1 of 2025.
The sharp decline in demand for medical X-ray imaging solutions that started in
July 2023 has stabilized. Challenges in the Chinese market, including healthcare
reform and the associated anticorruption campaign, delayed purchasing decisions.
However, as the effects of the anticorruption campaign have begun to fade, we
anticipate a return to growth in sales during Q1.
Our security business demonstrated better-than-expected performance, with sales
showing growth despite a strong underlying quarter. The growth was primarily
driven by robust demand for security CT and cargo imaging solutions. Key
contributors included aviation system upgrades and increased global investments
in border protection. We anticipate a temporary decline in security sales due to
delays in airport construction in Q1 and growth to start in Q2.
We are pleased with the reduction in working capital, strong cash flow, and
especially the improved net result in Q4. The positive development was driven by
growth in net sales, enhanced productivity, and a favorable sales mix.
The ramp-up of the Indian facility is progressing with deliveries set to start
in late H1 2025. Similarly, the expansion of EU-origin manufacturing in Oulu has
progressed as planned, enabling us to produce 10% of our global product sales in
Finland. These efforts enhance customer experience and mitigate risks against
the macro-economic uncertainties.
To advance our strategy and competitiveness, we have adopted a new operating
model. Since the beginning of this year, the newly established regional business
units have taken full responsibility for driving sales and strengthening
customer relationships. This shift lays a resilient foundation for our future
growth.
Despite heightened turbulence in global markets and fierce price competition in
China, the year-on-year market outlook has shown improvement. In 2025, the
growth drivers remain consistent across all our key markets. The new 25% tariffs
imposed by the US on Canada and Mexico, and the additional 10% tariff on China
have only a minor direct impact on our profitability.
In our assessment, global demand for medical X-ray imaging solutions is
beginning to recover in Q1. Security sales are expected to drop temporarily in
Q1 and return to growth in Q2, while industrial sales remain good. When
projecting the sales performance of our newly established regional business
units for Q1, we anticipate stable sales in all regions. Overall, we expect our
year-on-year total net sales to be flat in Q1, followed by double-digit growth
in Q2 of 2025 as medical sales return to growth.”
Key figures
(EUR 1,000) 10-12/2024 10-12/2023 1-12/2024 1-12/2023
Net sales 31,613 31,315 107,514 103,794
Change in net sales, % 0.9% 10.9% 3.6% 5.3%
EBITA excluding NRI 5,166 4,622 14,892 9,656
EBITA excluding NRI, % 16.3% 14.8% 13.9% 9.3%
Non-recurring items (NRI) 0 0 0 -873
EBITA 5,166 4,622 14,892 8,784
EBITA, % 16.3% 14.8% 13.9% 8.5%
R&D costs 3,125 2,723 11,379 11,702
R&D costs, % of net sales 9.9% 8.7% 10.6% 11.3%
Cash flow from operating 6,891 2,987 20,133 9,672
activities
Net interest-bearing debt -27,767 -12,665 -27,767 -12,665
at end of period
Investments 485 1,121 2,218 14,426
Return on investment (ROI), 17.4% 9.9% 17.4% 9.9%
Gearing, % -33.6% -17.4% -33.6% -17.4%
(diluted), EUR
Number of shares at the end 14,655,930 14,655,930 14,655,930 14,655,930
of the period
Weighted average number of 14,655,930 14,655,930 14,655,930 14,655,930
shares outstanding
Weighted average number of 14,659,106 14,655,930 14,660,744 14,660,912
shares outstanding, diluted
Business outlook
Detection Technology expects its year-on-year total net sales to remain stable
in Q1 and to achieve double-digit growth in Q2 of 2025.
Geopolitical situation, possible new US import tariffs, U.S.–China relations,
global economy, China’s healthcare reform, price competition especially in
China, the indirect impacts of the war in Ukraine, and events in the Middle East
create uncertainty.
Detection Technology aims to increase its sales by at least 10% per annum and to
achieve an operating margin (EBITA) of 15% in the medium term.
Q4 2024 webcast
Hannu Martola, the President and CEO of Detection Technology, will present the
Q4 and January–December 2024 financial performance and events to analysts,
investors, and media at a webcast. The live webcast in English will begin on 6
February 2025 at 13:00 (EET).
A link to the webcast is available on the company’s website at
https://www.deetee.com/reports-and-presentations/webcasts/. A recording of the
webcast will be accessible on the same page.
This release is a summary of Detection Technology’s financial statements review
January–December 2024. The complete report can be found attached to the release
and on the company’s website.
Board of Directors, Detection Technology Plc
Further information
President and CEO Hannu Martola will be available for interviews and further
information on the release date at 9:00-11:00 (EET).
Hannu Martola, President and CEO
Nordea is the company’s Certified Advisor under the Nasdaq First North GM rules,
Detection Technology is a global provider of X-ray detector solutions and
services for medical, security, and industrial applications. The company’s
solutions range from sensor components to optimized detector subsystems with
ASICs, electronics, mechanics, software, and algorithms. It has sites in
Finland, China, France, India, and the US. The company’s shares are listed on
Nasdaq First North Growth Market Finland under the ticker symbol DETEC.
Distribution: Nasdaq Helsinki, key media, www.deetee.com
If you would rather not receive future communications from Detection Technology Oyj, please go to https://optout.ne.cision.com/en/Zrix5mikUzoLGkcQfHrWY8d2tpdfcQWXV3VdXs7XBvo46UQ7itqvN9cSZ69PutWfTL2i2vxRp133bhWmX72TVFJvWpKfMJHRNtaot4vLx65LQ.
Detection Technology Oyj, A Grid, Otakaari 5A, Espoo, 02150 Finland
————————————————————
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
If you would rather not receive future communications from Detection Technology Oyj, please go to https://optout.ne.cision.com/en/Zrix5mikUzoLGkcQfHrWY8d2tpdfcQWXV3VdXs7XBvo46UQ7itqvN9cSZ69PutWfTL2i2vxRp133bhWmX72TVFJvWpKfMJHRNtaot4vLx65LQ.
Detection Technology Oyj, A Grid, Otakaari 5A, Espoo, 02150 Finland
Report this content
Trending
- Condono, Bonelli (AVS): «Meloni come Berlusconi. Legalizza le illegalità e punisce i cittadini onesti»
- Agenzia nr. 2157 – Sanità, Mazzotta (FI): “Depositata la proposta di legge per l’Osservatorio regionale sul diritto alla cura
- ASL Lecce: Screening oncologici nelle persone trans e gender diverse, esperti a confronto per una prevenzione più inclusiva
- Il Vescovo Augusto ‘paroliere’ in “Come una cerva anela” oratorio musicale con oltre 100 elementi sabato 21 e domenica 22 nelle cattedrali di Pescia e Pistoia con le musiche del Maestro Giovanni Proietti Modi
- Saldo IMU, arrivano gli assistenti digitali: risposte chiare e personalizzate 24 ore su 24
- Cs. n.457 Il 20 novembre un convegno per l’infanzia e l’adolescenza il Comune, di Ragusa presenta i risultati dei progetti educativi + locandina
- La musica delle parole: a Monopoli arriva Play Your Voice
- Screening nella Casa di Comunità di Senise
- Antisemitismo, Giglio Vigna (Lega): Legge di civiltà, la sinistra attacchi Hamas con lo stesso vigore
- UGEI: “DDL ANTISEMITISMO APPROVATO, L’ITALIA SCEGLIE DI NON VOLTARSI DALL’ALTRA PARTE”